Deputy CSO, Research Headquarters Corporate Officer, Taisho Pharmaceutical Co., Ltd.
Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Drug Discovery.Register Now
The Drug Discovery and Development Roundtable Discussion Strategy Meeting Japan is aim to gather Senior Executives of Early Drug Discovery (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities to exchange ideas and present cutting-edge discoveries, research and new therapeutic drugs and to determine successful R&D and partnering strategies being used by pharmaceutical and biotechnology companies to build their drug pipelines.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
- Chemistry, Immunology Chemistry, Chemistry Technologies, Medicinal and Innovative Chemistry, Drug Discovery & DMPK, Chemical and Molecular Therapeutics, Chemical Development, Biochemistry & Molecular Pharmacology, Computational and Structural Chemistry, Biochemistry.
Important: Roundtable discussion will be in Japanese language and Keynote presentation will be in English translated into Japanese.
Rodney Stevens, Ph.D
Taisho Pharmaceutical Co., Ltd.
Deputy CSO, Research Headquarters Corporate Officer
Vice President, Medicinal Chemistry, Jubilant Biosys Ltd
Executive Director, Medical Strategy, Medical Affairs, MSD K.K
Director, BioDynamics Research Foundation
Senior Director, Head of External Science and Innovation, Pfizer
Director, Business Development & Alliance, GlaxoSmithKline
Head of Drug Discovery Department Center for Development of Advanced Medicine for Dementia (CAMD), National Center for Geriatrics and Gerontology (NCGG)
SponsorsSee All Of Our Sponsors
Medicinal Chemistry Strategy Meeting APAC 2016,
Grand Prince Hotel New Takanawa